Dr. Harman CEO/Founder of VetStem Biopharma, the first US-based commercial veterinary stem cell company. In 2018, he co-founded Personalized Stem Cells, Inc., a human stem cell company that uses the 16 years of veterinary regenerative medicine therapy data to support translation in the human clinics. He is currently CEO of PSC. VetStem is also a formal CDMO for manufacturing human cell therapy products in FDA-inspected GMP facilities. Prior to that, he was CEO of a preclinical CRO for veterinary and human pharmaceutical development. He has overseen over 500 FDA animal studies and authored 15 peer-reviewed publications and book chapters on stem cell therapy. He received his Doctor of Veterinary Medicine and Master’s in Epidemiology from the University of California, Davis.